Beauty

Blood Sugar

Brain Health

Contract Manufacturing

Delivery Systems

Digestive Health

Food & Beverage

Heart Health

Herbs & Botanicals

Immune Support

Joint & Bone Health

Omega-3

Pet Health

Protein

Science

Sports & Energy

Stress & Sleep

Vitamins & Minerals

Weight Management

Women's Health

News

All News

Regulatory

Trends & Business

Media

Webcasts

Podcasts

Awards

Fun Facts

Publications

E-Books

Conferences

Subscribe

Resources

e-Learning Tools

Industry Insights

Nutritional Outlook is the leading news resource for manufacturers of dietary supplements, healthy foods, and nutrition beverages, from research to regulations.

About Us

Advertise

Contact Us

Editorial Submissions

Editorial Advisory Board

Do not sell my Information

Terms and Conditions

Privacy

Nutritional Outlook

Facebook

LinkedIn

Spotlight

 Contract Manufacturing

Topics

1rem

Authors

At SupplySide West 2023, Nutritional Outlook spoke with experts from GELITA to learn more about the company's products and mission.

GELITA: Improving Quality of Life

Immune Health  - XSTO – 9am EDT – 9:45am EDT

Heart Health – HP Ingredients – 10am EDT – 10:45am EDT

Sports Nutrition – Gelita – 11am EDT – 11:45am EDT

Bone Health – PLT Health – 1pm EDT – 1:45pm EDT

Beauty Ingredients – Nutrition 21 – 2pm EDT – 2:45pm EDT

Women’s Health – GE Nutrients – 3pm EDT – 3:45pm EDT


Nutritional Outlook’s 2021 Condition-Specific Symposium

 and reminds us to soak in all the amazing achievements women have made to the nutraceutical space.

 is putting the spotlight on women by compiling women-related content, new and old. From research to health and wellness, women are such an important part of the nutraceutical space that 

is dedicated to covering closely. Enjoy International Women’s Day 2025!

Read more on women-led omega-3 research advances wellness for all women’s life stages.

Highlighting research on women's health and wellness, part I

In this compilation, we present recent research on menstruation and skin health. Check out studies on pain management, natural supplements for skin appearance, and even stress and sleep support.

Celebrating International Women's Day: Highlighting research on women's health and wellness, Part II

In the second part of our research spotlight, we present recent research on pregnancy and menopause.

To celebrate International Women's Day (March 8) we are highlighting articles and roundtables, produced in partnership with Women in Nutraceuticals, on women’s health research and the role of women leaders driving innovation and equity in the industry.

Stay tuned for more International Women's Day-themed content! We will be updating this landing page throughout this week.

International Women’s Day. International Women’s day 2025 campaign theme: Accelerate action 

Check out our exciting 2025 International Women's Day coverage!

Women In Nutraceuticals

Topic

Nutritional Outlook celebrates International Women's Day 2025

OmniActive Health Technologies (Bridgewater, NJ and Mumbai, India) has announced a partnership with the Council for Responsible Nutrition (CRN; Washington, D.C.) to educate and raise awareness about the role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy among obstetricians, gynecologists, and other maternal healthcare practitioners. This knowledge will be shared at The American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical & Scientific Meeting. OmniActive is 

one of six companies CRN has partnered with

 to showcase the latest research and developments in prenatal nutrition through a specially designed “Prenatal Nutrition Center” at the conference. 

“It’s wonderful to have OmniActive as one of our featured partners during the ACOG annual event to help spread the word on the importance of prenatal nutrition,” said Andrea Wong, PhD, senior vice president, Scientific & Regulatory Affairs for CRN, in a press release. “CRN continues our efforts in supporting supplement manufacturers and ingredient suppliers in bringing clinically studied products to consumers to help meet their nutritional needs. Advancing awareness at the physician’s level is a huge part of this equation and this meeting is an effective way of reaching them.”

Citing market research from SkyQuest Technology, OmniActive explains in its press release that prenatal supplement sales were estimated to be at $740 million in 2023 and projected to rise to $1.4 billion by 2031. Similarly, a recent 

 found that about 60% of gynecologists think that 80-100% of their pregnant patients take dietary supplements. There is therefore a great deal of opportunity to grow and advance this category. Lutein and zeaxanthin are known for their support of eye health, but these benefits are relevant during pregnancy as well, says Deshanie Rai, PhD, FACN, vice president of Global Science, Regulatory and Advocacy at OmniActive Health Technologies.

“Current evidence supports the preferential accumulation of lutein and zeaxanthin in the human eye and neural tissues during pregnancy, especially during the third trimester. This suggests that lutein may play a functional and protective role in infant visual and cognitive development. As part of our Lutein for Every Age campaign, our goal is to help educate healthcare practitioners on this latest nutritional science research and the benefits of achieving adequate dietary lutein during pregnancy,” said Rai, in a press release. “OmniActive is proud to partner with the CRN Foundation’s Prenatal Nutrition Centre to promote awareness among healthcare practitioners on the nutritional relevance of lutein for both mom and baby.”

The educational initiative, “Lutein for Every Age,” focuses on raising awareness of early and consistent lutein and zeaxanthin intake to help support eye, cognitive, and general health throughout life, explains OmniActive. The AOCG meeting is taking place from May 17-19, 2024 in San Francisco, CA.

OmniActive Health Technologies has announced a partnership with the Council for Responsible Nutrition to educate and raise awareness about the role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy among obstetricians, gynecologists, and other maternal healthcare practitioners. 

OmniActive partners with CRN to raise awareness about macular carotenoids for prenatal health

The gut health category is growing and getting more sophisticated. Learn the gaps and best practices in microbiome research to inform your research and development.

https://www.nutritionaloutlook.com/no_w/gut-health

Scientific literature about the gut microbiome continues to grow, leading to rapid new product development. Let’s explore some of this scientific literature to take stock of what is known so far, and what remains to be known. Inform your gut microbiome research and new product development with the latest developments in research best practices and microbiome benefits.

Explore gaps in microbome research to inform future studies and expand knowledge

Learn best practices for microbome research to develop more reliable research and new products

Review the science behind microbiome supportive ingredients to ensure products are developed on a sound scientific foundation.


Postdoctoral Researcher
UC Los Angeles

Dr. Tatiana Diacova completed her PhD at UC Davis in Nutritional Biology. Dr. Diacova is now a Postdoctoral Researcher at UC Los Angeles. She has served on the IAFNS Best Practices for Diet-Gut Microbiome Research committee that recently published an umbrella review discussing best practices, considerations and gaps in knowledge for diet-gut microbiome studies. Tatiana has also recently completed two human trials exploring the effects of walnut and olive oil polyphenols on cardiometabolic health and the gut microbiome. She is currently serving as a Co-Investigator on several additional RCTs aiming to determine the effects of watermelon and pecan food components on whole-body antioxidant capacity, metabolic and gut health.




Scientific Director
International Probiotics Association

Jessica A. Younes, PhD has been IPA's Scientific Director since 2018, bringing both commercial and academic scientific expertise from international biotic supplement, pharmaceutical, and nutrition sectors. She specializes in women’s health and holds a PhD in Medical Microbiology and an MSc Nutrition and Nutraceutical Sciences. Spearheading IPA’s efforts to protect the scientific integrity of the biotic family, she additionally drives a proactive scientific agenda and helps to define and solidify the scientific identity and reputation for the Association. Passionate about all things related to microbes, products, and people, but especially the strategic and responsible translation of biotic science. When you speak with her next, ask this question: “which biotic would win at a game of chess”? You might just be surprised at her answer. 

Webinar Date/Time:
Wed, May 28, 2025 1:00 PM EDT

Webcasts: Health Focus

Gut Health, Under the Microscope

On March 10th, 2025, HHS Secretary Robert F. Kennedy Jr. instructed the acting FDA commissioner to explore potential rulemaking to eliminate the self-affirmed pathway for establishing a substance as Generally Recognized as Safe (GRAS). Under the current GRAS system, companies can independently determine that a substance is safe for use in food without requiring formal FDA approval, as long as there is consensus among qualified experts. Eliminating this pathway would require companies to notify the FDA before marketing substances as GRAS—a rule that the FDA has previously acknowledged exceeds its statutory authority. Regardless, any attempt to change the GRAS framework is likely to face significant challenges, including strong industry resistance and resource constraints, making both rulemaking and broader legislative reform difficult to achieve. Past attempts to review all GRAS substances have proven cumbersome, and some of the most concerning substances, such as color additives, are already excluded from the self-GRAS process. Given these challenges, the FDA may be better served by focusing its efforts on identifying and banning the highest-risk substances rather than eliminating the self-GRAS pathway entirely.

The concept of GRAS dates back to the passage of the Food Additives Amendment to the FDCA (Federal Food, Drug, and Cosmetic Act) in 1958. The act gave the FDA the authority to regulate food additives to ensure they are safe for human consumption. However, recognizing that many substances used in food (example common spices, salt) had long been safely consumed, Congress created the GRAS exemption, allowing certain substances to bypass the food additive approval process.

The FDA first published a list of generally recognized as safe (GRAS) substances in the Federal Register of December 9, 1958. This list came to be called the GRAS list. The current GRAS list appears as Parts 182, 184, and 186 of the Code of Federal Regulations (CFR).

FDA Removes Cyclamate; Nixon Orders Comprehensive Review

The FDA removed cyclamate salts from the GRAS list after studies linked them to an increased risk of bladder cancer in laboratory animals. In response, President Nixon ordered the FDA to reassess the safety of all GRAS substances under modern scientific standards to ensure they remained safe.

The FDA launched a full-scale review of all presumed GRAS substances. This involved evaluating the scientific evidence supporting each substance’s safety and determining if it should retain GRAS status. The FDA introduced a petition-based process, allowing manufacturers to seek confirmation of GRAS status. However, the process was highly time-consuming, taking up to 6 years (72 months) for the FDA to respond to a single petition.

After more than a decade, the FDA determined that the petition-based GRAS review process was unsustainable. The agency stopped conducting active GRAS reviews but continued to respond to petitions on a case-by-case basis when submitted by manufacturers.

Proposed Rule for Voluntary GRAS Notification

To reduce the regulatory burden and accelerate the review process, the FDA introduced a voluntary GRAS notification program through a proposed rule.

Under this system, companies could independently determine that a substance was GRAS based on publicly available scientific evidence and the consensus of qualified experts. Companies could notify the FDA of their determination, and the FDA would evaluate the evidence. If the FDA had no questions or objections, the company could proceed with marketing the substance without waiting for formal FDA approval. The FDA took about an average of 5 months (162 days) to respond. The FDA believed this would encourage companies to notify them rather than relying solely on self-affirmation.

FDA Issues GRAS Final Rule Formalizing the Notification Procedure

The FDA issued the GRAS final rule formalizing the GRAS notification program, clarifying that GRAS status must be supported by publicly available evidence and the consensus of qualified experts. The FDA retained the right to challenge a substance’s GRAS status if new scientific evidence raised safety concerns.

However, companies could still market substances as GRAS without notifying the FDA, provided they could demonstrate expert consensus on safety.

FDA’s rulemaking authority is derived from the FDCA and other statutes enacted by Congress. The FDA has the authority to issue regulations and guidelines to implement and enforce the provisions of these laws, but its rulemaking power is limited to the scope of authority expressly granted by Congress. The FDA cannot unilaterally impose new statutory requirements, eliminate existing exemptions, or fundamentally change the intent and purpose of a statute without Congressional approval. Here, the primary question remains: would requiring FDA approval for all GRAS substances effectively dismantle the GRAS exception altogether?

This issue touches on the broader statutory authority of the FDA and the legislative intent behind the creation of the GRAS exception—an issue the FDA has previously addressed and concluded is beyond their statutory authority. During the 2016 GRAS rulemaking, some commenters urged the FDA to require companies to notify the agency when concluding that a substance is GRAS. In response, the FDA stated that it does not have “express statutory authority” to mandate GRAS notifications. The FDA explained that when Congress established the premarket approval requirement for food additives in the 1958 amendment, it deliberately excluded substances that are GRAS under their intended use from the definition of “food additive.” This exclusion reflected Congress’s determination that certain substances intentionally added to food do not need FDA premarket approval to ensure safety. The FDA, in both its 1997 proposed rulemaking and 2016 rulemaking, has acknowledged that manufacturers have been able to independently determine GRAS status without notifying the FDA, as permitted by statute. Thus, the FDA only has statutory authority to modify or clarify the criteria for determining GRAS status and the scientific basis for such determinations. Requiring FDA approval for all GRAS substances would effectively redefine “food additive” under the FDCA and close the GRAS exemption—something that would require an amendment to the FDCA.

Furthermore, Congress’s intent to maintain the GRAS exception was reinforced by the Food and Drug Administration Modernization Act (FDAMA) of 1997, which amended Section 409 of the FD&C Act to create a mandatory food-contact notification program for human food. Yet, Congress did not amend section 409 to require a mandatory premarket GRAS notification process.

To amend the FDCA and eliminate GRAS, Congress follows an extensive process that includes drafting, committee review, debate, voting, and presidential approval. Similarly, any change from the FDA will require formal rulemaking under the Administrative Procedure Act, which involves publishing a proposed rule, allowing public comments, and issuing a final rule based on feedback. Through either avenue, both the FDA and Congress would face many challenges:

Industry resistance and lobbying efforts:

Powerful lobbying groups would resist eliminating self-GRAS, citing increased costs and supply chain disruptions. This could lead to delays through political debates, legal challenges, and potential legislative actions, further hindering the FDA’s efforts to implement any such proposed rule. Furthermore, legal challenges from industry stakeholders on constitutional grounds could tie up the proposed rule in litigation for years, further delaying its implementation and possibly forcing revisions or abandonment of the proposal.

A cost-benefit analysis would be needed to weigh public health benefits against the economic burden on the food industry. Eliminating self-GRAS would increase compliance costs, testing expenses, and product development delays, particularly harming smaller companies and startups, potentially stifling innovation and consolidating market power among larger manufacturers.

Shifting safety assessments to the FDA would require more staff, funding, and scientific review capacity, leading to longer approval times, increased costs, and internal resistance due to resource constraints, undermining the FDA’s efficiency. Historical precedent, such as President Nixon’s call for a comprehensive GRAS review, shows that reviewing every GRAS substance would be burdensome given current staffing and budgetary constraints.

Executive Order 14192 and the Trump administration’s focus:

Executive Order 14192, titled “Unleashing Prosperity Through Deregulation” mandates that for every new regulation issued, federal agencies must identify and eliminate at least ten existing regulations. Eliminating self-GRAS would also contradict the current administration’s stance on reducing regulatory burdens and promoting business-friendly policies.

In an announcement video posted on X, the HHS Secretary specifically mentioned concerns over Red 40, Yellow 5, and Yellow 6 in the U.S., misclassifying them as “generally recognized as safe” (GRAS). However, color additives are not classified under GRAS, as they are all subject to FDA approval. Under the FDCA, all color additives, as well as new uses for listed color additives, must be approved by the FDA before they can be used in foods, drugs, cosmetics, or certain medical devices, or applied to the human body. There is no GRAS provision for color additives within the statutory definition. This distinction is critical, as it underscores a common misconception about the regulatory framework surrounding these substances and highlights ongoing challenges in achieving scientific consensus. Even FDA-approved substances, such as artificial colorants, may face conflicting scientific assessments as new research emerges—Red Dye No. 3, for example, was recently banned. Thus, many of the most pressing public health concerns regarding food additives, such as food dyes, cannot be resolved simply by eliminating the self-GRAS process.

State actions, such as West Virginia’s recent ban on these color additives, further complicate public discourse. States have the authority to impose stricter regulations based on their own health and safety concerns, even when substances are federally approved. While the FDA may deem these dyes safe, some states, citing studies linking the dyes to behavioral issues in children, have opted to impose bans. This creates a fragmented regulatory environment, where food manufacturers must navigate a patchwork of regulations.

The underlying scientific and regulatory conflict persists, regardless of whether self-GRAS is eliminated. The tension between state and federal regulation complicates efforts to ensure consistent and reliable food safety standards. A more effective solution may not be the elimination of self-affirmed GRAS, but rather a continuous, rigorous scientific evaluation of potentially harmful substances. This approach should include regular inspection and consistent enforcement by FDA to ensure that all substances used in food products are safe, even for those that have not been formally notified to the FDA.

At this stage, nothing has changed. The self-affirmed pathway for GRAS is far from being eliminated. Challenges related to FDA rulemaking authority, industry resistance, and resource limitations will delay any major changes to the current framework. However, companies may encounter increased litigation and heightened regulatory scrutiny, particularly for those that have self-affirmed GRAS for certain substances. To prepare for potential legal and regulatory challenges, companies that have self-affirmed GRAS status can:


Ensure that the scientific data supporting each self-affirmed GRAS substance is comprehensive, up-to-date, and robust enough to withstand legal and regulatory challenges.

Be prepared to conduct additional studies to address emerging safety concerns or evolving public health debates that could arise.

Monitor and prepare for regulatory and legal changes:

Regularly review internal processes to ensure compliance with existing regulations and proactively prepare for potential future changes to avoid disruptions and maintain customer confidence.

If you have any questions about GRAS, Food Additives, Color Additives, New Dietary Ingredient Notifications, contact Talati Law Firm PLLC at 

HHS and FDA consider major changes amid legal and industry pushback.

The GRAS system at a crossroads

As the sports nutrition category expands, more consumers—not just athletes and highly active individuals—are looking for ways benefits from these supplements can apply to everyday life. In turn, manufacturers looking to offer consumers new products have several ways to explore this expansion of the category.

As Laura Kunces, PhD, RD, CSSD, vice president of medical strategy at Thorne, explains in an interview with 

, “Everyone has a different definition of performance. It can be defined as your job you need to do, whether that is being a professional athlete or an athletic professional, or even just a general human being; there are numerous areas of overlap.” Nonathletes can benefit from performance supplements in some instances, she adds, due to health issues, changes in stages of life, genetic concerns, or gaps in diets.

Similarly, Susan Hewlings PhD, RD, co-founder of Substantiation Sciences, sees the new reach of the category as an opportunity. “This opens the door for formulating and marketing because it targets active people which can also include people who are trying or wish they were more active,” she explains. “This is in contrast to the ‘athletes’ that sports nutrition used to target. These people were more serious, more hard-core and very focused on performance and recovery. The active consumer has a broader area of interest and is trying to fit working out into their everyday responsibilities. This opens the door to many more categories, and with small changes more closely mirrors the general population but still has a sports and active vibe to the messaging.” One example Hewlings provides the is the goal of offsetting muscle loss due to aging, which is less about “gains” and more about remaining active in the long-term.

Ingredients like protein and creatine which have historically been associated with enhancing the performance of athletes can still benefit consumers with different active nutrition goals, Hewlings explains. Additionally, she points out, protein and creatine have an established record of safety. Notably, based on data from SPINS from the 52 weeks ending October 6, 2024, creatine was among the top 10 ingredients in the performance category of the mainstream multioutlet channel, with $51,573,676 in sales, a 46.5% increase from the previous year. Additionally, creatine is starting to be recognized by women as important to their unique physiology, Kunces notes.

“Ingredients rarely have one purpose,” Kunces explains. “Take collagen for example. Popular in the skin health industry, it’s a staple for athletes, but also in the aging population too. The same goes for electrolytes, creatine, fish oil, and many more nutrients that have benefits that extend beyond the field or the gym. Educating the consumer on why they need it, the research on doses and timing for their desired use cases, and meeting them with the right format (powder, capsule, etc.) is the bigger challenge.”

Nutrition and diet education can also be an important factor in supplementation choice. As a recently published 

noted, even among athletes, inadequate nutrition is occasionally replaced by supplementation as compensation. The review also noted prior studies demonstrating that protein and creatine were commonly used by athletes to enhance muscle repair and performance, with other supplements being vitamin D and vitamin C.

Carbohydrates do not necessarily get enough recognition as a sport ingredient, Hewlings suggests, as they are necessary for fuel for active people and can provide B vitamins and fiber. Vitamin D is also important not just for immunity support, but for recovery and muscle heath in extensive training. Kunces also identifies vitamin D, along with magnesium, as overlooked and that most Americans are insufficient or deficient in, while athletes may want to consider higher levels.

Kunces identifies curcumin as another ingredient for athletes and non-athletes to consider. “It helps to maintain a healthy inflammatory response in the whole body – including muscles, joints, GI tract, liver, brain, [and] nerves,” she explains. “Inflammation doesn’t have to be caused by physical exercise, as we see so many environmental, lifestyle, and dietary factors causing inflammation in the body.”

Whey protein is also becoming more in-demand, she adds. “People are recognizing the benefits of having protein at every meal to help stabilize metabolism, improve satiety, and meet nutritional needs with a convenience product,” Kunces explains. “Also, when protein is mixed with other powder nutrients like creatine, fiber, magnesium, it’s an easy way to build a personalized nutrition smoothie for anyone’s needs.”

The formulation of these kinds of products requires different considerations of consumer needs, though efficacy and compliance are the most important, Kunces explains. “High-quality, research backed, and sustainable ingredients that can then be put into the right format for user convenience while making sure it tastes good are all key pieces to the consideration puzzle.” Factors such as age group, health goals, health conditions, medications, and interactions with other formulations are also to be taken into account when formulating for certain populations.

“Match your science to your population,” Hewlings suggests. Ensure the research supports the claims for the target population and that the mechanisms of action are sensible.

Hopper, C.; Mooney, E.; Mc Cloat, A. Nutritional Intake and Dietary Knowledge of Athletes: A Scoping Review. 

Athletes and nonathletes alike can benefit from supplements that support muscles, energy, and nutrients for a variety of activities.

Formulating for everyday performance

The ingredient most synonymous with energy is caffeine. Based on data from SPINS from the 52 weeks ending October 6, 2024, caffeine was featured in the top 10 ingredients in the energy category of the natural channel, with 23.9% sales growth for a total of $2,292,775 in sales. In the performance category of the mainstream multioutlet channel, caffeine also ranks in the top ten with $22,923,614 in sales, a 3.6% increase from the previous year. Additionally, within the mainstream channel, caffeine is among the 25 top-selling functional ingredients, but did experience a 7.6% decrease in sales. Despite its importance and popularity as an energy ingredient, within the energy category of the natural channel, for example, other ingredients such as B vitamins outsell caffeine. Therefore, a successful energy product requires more than the reliable boost of caffeine as consumer seek healthier energy solutions.

 on energy drinks noted that the most prevalent ingredients out of the top 75 selling drinks in the U.S. in 2021 were caffeine, sugar, B vitamins, electrolytes, and taurine. Typically, energy is sourced from stimulants such as caffeine, though this comes with drawbacks. Anxiety, jitters, and sleep disturbances are common effects from caffeine that consumers seek to avoid, especially if their goal is increased concentration. As 

 has shown, adolescents and pregnant women are more sensitive to the effects of caffeine, which can pose dangers to health. Even long-term use of energy drinks in older adults resulted in negative cardiovascular effects.

Overall, as Susan Hewlings PhD, RD, co-founder of Substantiation Sciences explained in an interview with 

, “The term ‘energy’ needs to be carefully considered…it is most often associated with the acute ‘awakening’ you get from caffeine and other stimulants but that is not always what consumers are seeking. Many want more of a long term offset to chronic fatigue or an increased motivation or an increased focus.”

Caffeine for quick and easy energy, though common and readily accessible, may not be a suitable choice for all consumers. Alternative ingredients have been emerging with the potential to help consumers achieve their energy goals. For example, Hewlings notes that the caffeine metabolite paraxanthine is processed quickly and does not result in jitters. Additionally, theacrine is similar to caffeine, without the addictive effects.

Aside from alternatives to caffeine and stimulants as an energy source, there are alternate mechanisms of action for energy production in the body. “Part of the challenge in this space is one of identity and differentiation,” Hewlings explains. “I suggest knowing what ‘energy’ you are targeting because they have different mechanisms of action and will therefore require a different ingredient. Typically, when consumers are seeking a caffeine alternative they are seeking to avoid side effects which are very individual.”

Laura Kunces, PhD, RD, CSSD, vice president of medical strategy at Thorne, explains that deciding on an energy source may take a holistic approach for the consumer, and can involve examining diet and nutrition intake as well as overall health and goals. Deciding on a supplement goes deeper than a conventional stimulant. “Differences in energy production can be realized at the cellular, tissue, and organ levels influencing actual energy production and our perception of feeling energized,” Kunces says. “Some supplements provide direct energy in the form of calories. Examples are macronutrients like carbohydrates, fat, or protein. Some help maintain the structure and function of a cell so it can properly do its job, like DHA or iron. Some supplements can work to mitigate the underlying issue that is preventing proper energy production.”

Carbohydrates, a common dietary source of energy, for example, “provide direct energy (calories) and break down into glucose for quick entrance into the bloodstream. They can provide significant ATP for the functioning body,” explains Kunces.

Other ingredients may be effective at supporting both mental and physical energy. “Creatine is a key component of the phosphocreatine system, helping the muscles create and regenerate the energy demands for a few seconds of intense movements, from hoisting a kid to your shoulders to doing a back flip. Intense cognitive thinking requires the same energy system, so creatine also plays a role in mental energy needs during periods of high demand, like at work or driving a car,” Kunces explains.

Additionally, some supplements such as B-vitamins and the amino acid beta-alanine provide indirect energy, but help energy metabolism or delay fatigue. Vitamins B

 in particular help convert carbs, fat, and protein into usable energy. Others support the transport of oxygen through the body by maintaining red blood cell structure. Nicotinamide riboside (NR), a form of B

 and a precursor to NAD+, also supports energy production. Finally, Acetyl-L-carnitine helps with focus, and mental clarity by supporting mitochondrial energy production.

Apart from micro and macronutrients, Kunces notes a few lesser-known sources of indirect energy: the herb Greek mountain tea, Lion’s mane mushrooms, and Alpha-GPC. She says that Greek mountain tea can support mental alertness by promoting blood flow to the brain, Lion’s mane supports cognition by helping stimulate the growth of neurons, and Alpha-GPC, popular with athletes, promotes physical stamina through human growth hormone production support.

Furthermore, when combined, many of the aforementioned ingredients may complement one another to provide a greater impact on energy. “A good multivitamin that contains a B-vitamin complex, magnesium, and iron can help make sure that food is broken down for energy, ATP is biologically active, and oxygen is being transported to aid in cellular respiration in the mitochondria,” Kunces explains “NR and polyphenols like resveratrol can help increase NAD+ levels and activate sirtuins that use the NAD to improve mitochondrial efficiency and output. L-carnitine with omega-3s, and alpha-lipoic acid can help enhance fat metabolism and mitochondrial efficiency. Electrolytes with water as hydration is key to maintaining metabolic processes.”

There are various mechanisms of action through which energy can be produced. Additionally, the way energy is experienced can differ depending on its source. More considerate energy options will allow consumers to achieve their energy goals with health in mind.

Antonio, J.; Antonio, B.; Arent, SM.; Candow, DG.; Escalante, G.; Evans, C.; Forbes, S.; Fukuda, D.; Gibbons, M.; Harty, P.; et al. Common Questions and Misconceptions About Energy Drinks: What Does the Scientific Evidence Really Show? 

With sustained interest in energy, alternatives to the typical caffeine and other stimulants can offer consumers a more personalized approach with fewer side effects.

Gelita

Articles

Latest Updated Articles